Additionally, we carried out in vivo rescue experiments in which WT or Tmed4-deficient CD45.2+ Tregs pretreated with DMSO and NAC, respectively, were inoculated into MC38 tumor cell–bearing CD45.1+ mice. Here, TMED4 is linked to neoplasm.